Instrument Inactif

Autres langues ALKERMES Nasdaq

Actions

Cours en clôture Nasdaq Autres places de cotation
- ^USD	-

17/06	ALKERMES PLC : TD Cowen à l'achat	ZM
11/06	Transcript : Alkermes plc Presents at Goldman Sachs 45th Annual Global Healthcare Conference, Jun-11-2024 10:40 AM

Autres langues

Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !

Inscription 100% Gratuite

Alkermes to Participate in Two Upcoming Investor Conferences	29/05
Alkermes to Present New Clinical Data for ALKS 2680 at SLEEP 2024	28/05
Alkermes plc Completes Sale of Athlone, Ireland Facility to Novo Nordisk	02/05
Alkermes : Q1 2024 Earnings Call Script FINAL 5 1 2024	02/05
Alkermes : ALKS Q1 2024 Earnings Slides FINAL 5 1 2024	02/05
Tranche Update on Alkermes plc's Equity Buyback Plan announced on November 21, 2007.	01/05
Alkermes's Q1 Earnings, Revenue Grow But Miss Street View	01/05
Alkermes: Q1 Earnings Snapshot	01/05
Earnings Flash (ALKS) ALKERMES Reports Q1 Revenue $350.4M, vs. Street Est of $360.3M	01/05
Earnings Flash (ALKS) ALKERMES Posts Q1 EPS $0.43, vs. Street Est of $0.58	01/05
Alkermes plc Reiterates Earnings Guidance for the Year 2024	01/05
Alkermes plc Reports Earnings Results for the First Quarter Ended March 31, 2024	01/05
Alkermes plc Reports First Quarter 2024 Financial Results	01/05
Alkermes Announces Initiation of Vibrance-1 Phase 2 Study Evaluating ALKS 2680 for the Treatment of Narcolepsy Type 1	24/04
Alkermes to Report First Quarter Financial Results on May 1, 2024	17/04
Alkermes Announces Positive Topline Results from Phase 1b Study of ALKS 2680 Demonstrating Improved Wakefulness in Patients with Narcolepsy Type 2 and Idiopathic Hypersomnia	10/04
BlackBerry, Alkermes rise; Neogen, Tilray Brands fall, Tuesday, 4/9/2024	09/04
Sector Update: Health Care Stocks Edge Higher Pre-Bell Tuesday	09/04
Alkermes Says Potential Narcolepsy Drug Improves Wakefulness in Phase 1b Study	09/04
Alkermes plc Announces Positive Topline Results from Phase 1b Study of ALKS 2680 Demonstrating Improved Wakefulness in Patients with Narcolepsy Type 2 and Idiopathic Hypersomnia	09/04

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues ALKERMES Nasdaq

Actions

Autres langues

Filtres